Form 4: Willis Towers Watson Executive Acquires Shares and Dividend Equivalent Rights
SEC Form 4 Filing
Imran Ahmed Qureshi, Head of North America at Willis Towers Watson, reports acquisition of shares and dividend equivalent rights.
Summary
- On October 15, 2024, Imran Ahmed Qureshi, Head of North America at Willis Towers Watson, acquired ordinary shares and dividend equivalent rights.
- Qureshi acquired 5.03 ordinary shares at $0.
- He also acquired 7.8019 restricted share units (RSUs) representing dividends from the Willis Towers Watson Non-Qualified Deferred Savings Plan.
- Additionally, 4.6152 RSUs were acquired representing dividends from the Willis Towers Watson Non-Qualified Stable Value Excess Plan.
- Finally, 1.056 dividend equivalent rights related to a 2022 RSU award were acquired.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing executive compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Positives
- The acquisition of shares and dividend equivalent rights reflects continued investment in the company by a key executive.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the holdings and transactions of company insiders. This filing indicates ongoing participation in company savings plans and dividend programs.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, restricted stock units, and other benefits.
- Dividend equivalent rights are a common feature of RSU awards, providing executives with the same dividend benefits as ordinary shareholders.
- Deferred savings plans and excess plans are typical components of executive compensation packages in large corporations, designed to attract and retain talent.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 10/15/2024 | Date of transaction: Acquisition of ordinary shares, restricted share units, and dividend equivalent rights. |
| 10/17/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.